Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

British Journal of Cancer

Volumn 74, Issue 6, 1996, Pages 874-880

  Nielsen, N H ^a   Arnerlov C ^a   Emdin, S O ^a   Landberg, G ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Cell cycle; Cyclin; Oestrogen receptor; Prognosis

Indexed keywords

CYCLINE; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR GROWTH; TUMOR VOLUME;

EID: 0029758105     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.451     Document Type: Article

References (44)

1. ADNANE J, GAUDRAY P, SIMON M-P, SIMONY-LAFONTAINE J, JEANTEUR P AND THEILLET C. (1989). Proto-oncogene amplification and human breast tumor phenotype. Oncogene, 4, 1389-1395.
2. ARNERLÖV C, EMDIN SO, ROOS G, ÄNGSTROM T, BJERSING L, ÄNGQUIST K-A AND JONSSON H. (1990). Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer. Eur. J. Surg. Oncol., 16, 200-208.
3. BUCKLEY MF, SWEENEY KJE, HAMILTON JA, SINI RL, MANNING DL, NICHOLSON RI, DEFAZIO A, WATTS CKW, MUSGROVE EA AND SUTHERLAND RL. (1993). Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8, 2127-2133.
4. BURTON K. (1968). Determination of DNA concentratiaons with diphenylamine. In Methods in Enzymology. Vol. 12, part B. Grossman L and Moldave K (eds) pp. 163-166. Academic Press: New York.
5. DOU Q-P, LEVIN AH, ZHAO S AND PARDEE AB. (1993). Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res., 53, 1493-1497.
6. DRAETTA GF. (1994). Mammalian G1 cyclins. Curr. Opin. Cell Biol., 6, 842-846.
7. DULIC V, LEES E AND REED SI. (1992). Association of human cyclin E with a periodic G1-S phase protein kinase. Science, 257, 1958-1961.
8. DUTTA A, CHANDRA R, LEITER LM AND LESTER S. (1995). Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc. Nutl Acad. Sci. USA, 92, 5386-5390.
9. FEICHTER GE, MUELLER A, KAUFMANN M, HAAG D, BORN IA, ABEL U, KLINGA K, KUBLI F AND GOERTTLFR K. (1988). Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. Int. J. Cancer, 41, 823-828.
10. HARTWELL LH AND KASTAN MB. (1994). Cell cycle control and cancer. Science, 266, 1821-1828.
11. HE J, ALLEN JR, COLLINS VP, ALLALUNIS-TURNER MJ, GODBOUT R, DAY RS AND JAMES CD. (1994). CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res., 54, 5804-5807.
12. HERMAN ME AND KATZENELLENBOGEN BS. (1994). Alterations in transforming growth factor-α and -β production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Cancer Res., 54, 5867-5874.
13. HORWITZ KB. (1994). Plenary lecture: How do breast cancers become hormone resistant? J. Steroid Biochem. Mol. Biol., 49, 295-302.
14. HUNTER T AND PINES J. (1994). Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
15. KEYOMARSI K AND PARDEE A. (1993). Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl Acad. Sci. USA, 90, 1112-1116.
16. KEYOMARSI K, O'LEARY N, MOLNAR G, LEES E, FINGERT HJ AND PARDEE A. (1994). Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54, 380-385.
17. KEYOMARSI K, CONTE JR. D, TOYOFUKU W AND FOX P. (1995). Deregulation of cyclin E in breast cancer. Oncogene, 11, 941-950.
18. KOFF A, CROSS F, FISHER A, SCHUMACHER J, LEGUELLEC K, PHILIPPE M AND ROBERTS JM. (1991). Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell, 66, 1217-1228.
19. KOFF A, GIORDANO A, DESAI D, YAMASHAITA K, HARPER JW, ELLEDGE S, NISHIMOTO T, MORGAN DO, FRANZA BR AND ROBERTS JM. (1992). Formation and activation of a cyclin E cdk2 complex during the G1 phase of the human cell cycle. Science, 257, 1689-1694.
20. KORNBLAU SM, XU H-J, ZHANG W, HU S-X, BERAN M, SMITH TL, HESTER J, ESTEY E, BENEDICT WF AND DEISSEROTH AB. (1994). Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood, 84, 256-261.
21. LAMMIE GA, FANTL V, SMITH R, SCHUURING E, BROOKES S, MICHALIDES R, DICKSON C. ARNOLD A AND PETERS G. (1991). D11S287, a putative oncogene on chromosome 1lq13, is amplified and expressed in squamous and mammary carcinomas and linked to BCL-1. Oncogene, 6, 439-444.
22. LEACH FS, ELLEDGE SJ, SHERR CJ, WILLSON JKV, MARKOWITZ S, KINZLER KW AND VOLGELSTEIN B. (1993). Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53, 1986-1989.
23. MATSUSHIME H, ROUSSEL MF, ASHMUN RA AND SHERR CJ. (1991). Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell, 65, 701-713.
24. MEYER JS AND PROVINCE MA. (1994). S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Cancer, 74, 2287-2299.
25. MOTOKURA T AND ARNOLD A. (1993). Cyclin D and oncogenesis. Curr. Opin. Genet. Dev., 3, 5-10.
26. MOTOKURA T, BLOOM T, KIM HG, JÜPPNER H, RUDERMAN, JV, KRONENBERG HM AND ARNOLD A. (1991). A novel cyclin encoded by a bell-linked candidate oncogene. Nature, 350, 512-515.
27. MUSGROVE EA, HAMILTON JA, LEE CSL, SWEENEY KJE, WATTS CKW AND SUTHERLAND RL. (1993). Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol., 13, 3577-3587.
28. MUSGROVE EA, LEE CSL, BUCKLEY ME AND SUTHERLAND RL. (1994). Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl Acad. Sci. USA, 91, 8022-8026.
29. INK4 in human cancer. Proc. Natl Acad. Sci. USA, 91, 11045-11049.
30. INK4B/ MTS2 in human leukemias and lymphomas. Cancer Res., 55, 1436-1440.
31. 1/S phase transition by expression of cyclin D1 and E with an inducible system. Mol. Cell. Biol., 14, 1669-1679.
32. SCHUURING E, VERHOEVEN E, TINTEREN H, PETERSE JL, NUNNINK B, THUNNISSEN FBJM. DEVILEE P, CORNELISSE CJ, VIJER MJ, MOOI WJ AND MICHALIDES RJAM. (1992). Amplification of genes within the chromosome 1lq13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52, 5229-5234.
33. SIGURDSSON H, BALDETORP B, BORG Å, DALBERG M, FERNÖ M, KILLANDER D AND OLSSON H. (1990). Indicators of prognosis in node-negative breast cancer. N. Engl. J. Med., 322, 1045-1053.
34. SLAMON DJ, GODOLPHIN W, JONES LA, HOlT JA, WONG SG, KEITH DE, LEVIN WJ, STUART SG, UDOVE J, ULLRICH A AND PRESS MF. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
35. SUTHERLAND RL, WATTS CKW AND MUSGROVF EA. (1993). Cyclin gene expression and growth control in normal and neoplastic human breast epithelium. J. Steroid Biochem. Mol. Biol., 47, 99-106.
36. TANDON AK, CLARK GM, CHAMNESS GC, CHIRGWIN JM AND MCGUIRE WL. (1990). Cathepsin D and prognosis in breast cancer. N. Engl. J. Med., 322, 297-302.
37. TASSAN J-P, SCHULTZ SJ, BARTEK J AND NIGG EA. (1994). Cell cycle analysis of the activity, subcellular localization and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol., 127, 467-478.
38. THEILLET C, ADNANE J, SZEPETOWSKI P, SIMON M-P, JEANTEUR P, BIRNBAUM D AND GAUDRAY P. (1990). BCL-1 participates in 1lq13 amplification forund in breast cancer. Oncogene, 5, 147-149.
39. VAN AGTHOVEN T, VAN AGTHOVEN TLA, PORTENGEN H, FOEKENS JA AND DORSSERS LCJ. (1992). Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res., 52, 5082-5088.
40. WANG TC, CARDIFF RD, ZUKERBERG L, LEES E, ARNOLD A AND SCHMIDT EV. (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature, 369, 669-671.
41. WATTS CKW, SWEENEY KJE, WARLTERS A, MUSGROVE EA AND SUTHERLAND RL. (1994). Antiestrogen regulation of cell cycleprogression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast C. Res. Treat., 31, 95-105.
42. WEINBERG RA. (1995). The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
43. WILLIAMS ME, SWERDLOW SH AND MEEKER TC. (1993). Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia, 7, 1437-1440.
44. XIONG Y, HANNON GJ, ZHANG H, CASSO D, KOBAYASHI R AND BEACH D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704.